BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9814562)

  • 1. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
    Kim HJ; Boyd J; Dunphy F; Lowe V
    Clin Nucl Med; 1998 Nov; 23(11):750-2. PubMed ID: 9814562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
    Lowe VJ; Kim H; Boyd JH; Eisenbeis JF; Dunphy FR; Fletcher JW
    Radiology; 1999 Sep; 212(3):799-802. PubMed ID: 10478249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.
    Cobben DC; van der Laan BF; Maas B; Vaalburg W; Suurmeijer AJ; Hoekstra HJ; Jager PL; Elsinga PH
    J Nucl Med; 2004 Feb; 45(2):226-31. PubMed ID: 14960640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
    Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
    HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of
    Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Case LD
    Cancer J Sci Am; 1997; 3(6):353-7. PubMed ID: 9403048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
    Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
    Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
    Stokkel MP; Terhaard CH; Mertens IJ; Hordijk GJ; van Rijk PP
    J Nucl Med; 1998 Aug; 39(8):1385-7. PubMed ID: 9708513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
    Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
    Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K; Hay JH; Wilson DC
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
    Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ
    Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma].
    Haenggeli CA; Dulguerov P; Slosman D; Becker M; Bang P; Allal A; Guyot JP; Lehmann W
    Schweiz Med Wochenschr Suppl; 2000; 116():8S-11S. PubMed ID: 10780061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas.
    Conessa C; Hervé S; Foehrenbach H; Poncet JL
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):628-35. PubMed ID: 15330142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
    Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
    Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
    Wedman J; Pruim J; van der Putten L; Hoekstra OS; de Bree R; van Dijk BAC; van der Laan BFAM
    Clin Otolaryngol; 2019 Mar; 44(2):124-130. PubMed ID: 30315624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.